Drug Type Small molecule drug |
Synonyms TNG917 |
Target |
Mechanism EHMT1 inhibitors(euchromatic histone lysine methyltransferase 1 inhibitors), EHMT2 inhibitors(euchromatic histone lysine methyltransferase 2 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Preclinical | US | 05 Mar 2024 |